Researchers develop an AI tool to predict cardiometabolic multimorbidity risk in type 2 diabetes, aiding early intervention and personalised care. Find out more.

CHICAGO, June 20, 2025 /PRNewswire/ -- Developments from two studies highlighting the potential for machine learning leveraging artificial intelligence (AI) technology to improve early-stage ...

MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...

University of Virginia School of Data Science researcher Heman Shakeri has been awarded a major new research grant to lead work at the intersection of machine learning and diabetes care. Shakeri will ...

DiaCardia, a novel artificial intelligence model that can accurately identify individuals with prediabetes using either ...